HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.705

-0.010-1.40%

Volume:35.27M

Turnover:25.23M

Market Cap:6.43B

PE:35.79

High:0.730

Open:0.720

Low:0.705

Close:0.715

52wk High:1.896

52wk Low:0.685

Shares:9.12B

HK Float Shares:9.12B

Volume Ratio:2.34

T/O Rate:0.39%

Dividend:0.01

Dividend Rate:1.59%

EPS(LYR):0.020

ROE:5.57%

ROA:2.80%

PB:0.89

PE(LYR):35.79

PS:2.09

Loading ...

Overview Company News Filings

Sihuan Pharmaceutical Proposes 2026 Share Incentive Scheme to Replace Existing Option Plan

Bulletin Express

SIHUAN PHARM (00460) Proposes Adoption of 2026 Share Incentive Scheme

Sihuan Pharmaceutical proposes adopting 2026 share incentive scheme to replace option plan

There May Be Underlying Issues With The Quality Of Sihuan Pharmaceutical Holdings Group's (HKG:460) Earnings

Simply Wall St.

Sihuan Pharmaceutical Reports No Share Capital Changes for April; Public Float Remains Compliant

Bulletin Express

四环医药控股集团2025年业绩回顾：营收同比增长37.7%，成功实现扭亏为盈

Bulletin Express

SIHUAN PHARM Publishes FY2025 Annual Report and ESG Report

Bulletin Express

SIHUAN PHARM (00460) Trustee Acquires 3 Million Shares Under Incentive Scheme

Sihuan Pharmaceutical share award scheme trustee buys 3,000,000 shares at HK$1.36 average

SIHUAN PHARM Shares Climb Nearly 3% as Subsidiary XUANZHUBIO-B Presents Promising Data on Diraoc in First-Line NSCLC Treatment at AACR

Xuanzhu says Phase 1b NG-350A plus chemoradiotherapy hits 50% composite response rate

Sihuan Pharma - Dirozalkib Shows Significant Efficacy Advantages in First-Line Alk-Positive Advanced Nsclc

THOMSON REUTERS

Sihuan Pharma - Xuanzhu Biopharm Presents Phase Iii Dirozalkib Data for Alk-Positive Nsclc at 2026 Aacr

THOMSON REUTERS

Xuanzhu says Phase III trial shows dirozalkib cuts lung cancer progression risk 53%

Xuanzhu Biopharma wins HKEX approval to list 357,245,794 converted H shares

Sihuan Pharm’s Xuanzhu Biopharm Secures CDE Approval for Phase III Trial of Anaprazole Sodium in Helicobacter Pylori Eradication

Bulletin Express

BUZZ-Xuanzhu Biopharmaceutical climbs to three-week high on approval for drug clinical trial

Xuanzhu Biopharma wins China CDE nod for Phase III Anaprazole H. pylori trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/00460/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00460","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":0.705,"timestamp":1791446897002,"preClose":0.715,"halted":0,"volume":35271772,"delay":0,"changeRate":-0.013986013986014,"floatShares":9116000000,"shares":9116000000,"eps":0.0197,"marketStatus":"Closed","change":-0.01,"latestTime":"10-08 16:08:17","open":0.72,"high":0.73,"low":0.705,"amount":25233769,"amplitude":0.034965,"askPrice":0.71,"askSize":428000,"bidPrice":0.705,"bidSize":661000,"shortable":3,"etf":0,"ttmEps":0.038573,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":0.715,"dividendRate":0.015928,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":2.341088,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","floatShares":9116000000,"roa":"2.80%","roe":"5.57%","lyrEps":0.0197,"volumeRatio":2.341088,"shares":9116000000,"dividePrice":0.011237,"high":0.73,"amplitude":0.034965,"preClose":0.715,"low":0.705,"week52Low":0.685,"pbRate":"0.89","psRate":"2.09","week52High":1.896,"institutionHeld":0,"latestPrice":0.705,"committee":0.213958,"eps":0.0197,"divideRate":0.015939,"volume":35271772,"delay":0,"ttmEps":0.038573,"open":0.72,"prevYearClose":1.215,"prevWeekClose":0.72,"prevMonthClose":0.73,"prevQuarterClose":0.73,"fiveDayClose":0.73,"twentyDayClose":0.775,"sixtyDayClose":0.93,"dividendGrowthYears":0,"dividendGrowthRate":-0.48095238095238096,"fiveYearAvgDividendRate":0.06241727605023266},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00460\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-06-30","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-07-02","defaultRemindTime":1782783000000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-16","payableDate":"2026-07-02","currency":"HKD","dateTimestamp":1782748800000,"payDate":"2026-07-16"},{"market":"HK","date":"2026-03-31","symbol":"00460","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"pre","actualEps":null},{"date":"2025-09-26","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-29","defaultRemindTime":1758850200000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-09-29","currency":"HKD","dateTimestamp":1758816000000,"payDate":"2025-10-10"},{"date":"2025-08-29","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00460\",market:\"HK\",,,undefined,":[{"executeDate":"2017-06-22","recordDate":"2017-06-23","paymentDate":"2017-07-05","value":0.061,"currency":"HKD"},{"executeDate":"2017-09-01","recordDate":"2017-09-04","paymentDate":"2017-09-13","value":0.021,"currency":"HKD"},{"executeDate":"2018-06-07","recordDate":"2018-06-08","paymentDate":"2018-06-20","value":0.016,"currency":"HKD"},{"executeDate":"2018-10-18","recordDate":"2018-10-19","paymentDate":"2018-10-31","value":0.005,"currency":"HKD"},{"executeDate":"2019-06-05","recordDate":"2019-06-06","paymentDate":"2019-06-19","value":0.015,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00460\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1776182400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00460\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00460","date":"2026-10-07","current":18.277033,"percent":0.817073,"low":-209.490836,"twenty":-129.621563,"median":-26.410489,"eighty":13.898064,"high":64.244472,"avg":-43.59418,"sd":66.624214,"marketCap":6431997147},"quantilePoints":[{"date":"2021-10-08","current":13.108229,"twenty":-22.959741,"median":35.979756,"eighty":50.46473,"marketCap":14802340263},{"date":"2021-10-15","current":13.579123,"twenty":-21.594681,"median":35.600566,"eighty":50.364548,"marketCap":15344610065},{"date":"2021-10-22","current":14.332089,"twenty":-19.026938,"median":35.395632,"eighty":50.002562,"marketCap":16311750418},{"date":"2021-10-29","current":13.511153,"twenty":-15.708182,"median":35.247968,"eighty":49.588904,"marketCap":15339395937},{"date":"2021-11-05","current":12.246285,"twenty":-12.19519,"median":34.988251,"eighty":49.223932,"marketCap":13926283816},{"date":"2021-11-12","current":12.011055,"twenty":-11.77144,"median":27.258382,"eighty":48.839902,"marketCap":13715098832},{"date":"2021-11-19","current":12.928135,"twenty":-11.732461,"median":19.402854,"eighty":48.776182,"marketCap":14741398745},{"date":"2021-11-26","current":13.414784,"twenty":-11.673993,"median":19.144523,"eighty":48.710704,"marketCap":15301198697},{"date":"2021-12-03","current":12.246976,"twenty":-11.652916,"median":18.619604,"eighty":48.61427,"marketCap":13994998809},{"date":"2021-12-10","current":12.796652,"twenty":-11.595138,"median":18.005665,"eighty":48.548604,"marketCap":14648098753},{"date":"2021-12-17","current":11.500484,"twenty":-11.464523,"median":17.782952,"eighty":48.516654,"marketCap":13155298880},{"date":"2021-12-24","current":11.652483,"twenty":-11.370198,"median":17.227082,"eighty":48.404807,"marketCap":13341898864},{"date":"2021-12-31","current":12.033737,"twenty":-11.352806,"median":16.727584,"eighty":48.276843,"marketCap":13808398824},{"date":"2022-01-07","current":11.997981,"twenty":11.916847,"median":12.033737,"eighty":12.311613,"marketCap":13715098832},{"date":"2022-01-14","current":13.437855,"twenty":11.991179,"median":12.354107,"eighty":13.277084,"marketCap":15394498689},{"date":"2022-01-21","current":12.838373,"twenty":12.019435,"median":12.923546,"eighty":13.260333,"marketCap":14741398745},{"date":"2022-01-28","current":11.730737,"twenty":11.950402,"median":12.53206,"eighty":13.186191,"marketCap":13435198856},{"date":"2022-02-04","current":12.062504,"twenty":11.904542,"median":12.319594,"eighty":13.174667,"marketCap":13808398824},{"date":"2022-02-11","current":13.095597,"twenty":11.980976,"median":12.566572,"eighty":13.174667,"marketCap":15021298721},{"date":"2022-02-18","current":14.893251,"twenty":11.997981,"median":12.857781,"eighty":13.345619,"marketCap":17167198539},{"date":"2022-02-25","current":13.968456,"twenty":12.033737,"median":12.929214,"eighty":13.75323,"marketCap":16140898626},{"date":"2022-03-04","current":12.913857,"twenty":12.062504,"median":12.988177,"eighty":13.600429,"marketCap":14927998729},{"date":"2022-03-11","current":13.175885,"twenty":12.074235,"median":12.990943,"eighty":13.53943,"marketCap":15207898705},{"date":"2022-03-18","current":13.228631,"twenty":12.062504,"median":12.970168,"eighty":13.471303,"marketCap":15207898705},{"date":"2022-03-25","current":13.390384,"twenty":12.074235,"median":13.001622,"eighty":13.556612,"marketCap":15394498689},{"date":"2022-04-01","current":28.56237,"twenty":12.077655,"median":13.05005,"eighty":13.891083,"marketCap":14648098753},{"date":"2022-04-08","current":27.095221,"twenty":12.083977,"median":13.125304,"eighty":14.447354,"marketCap":13901698816},{"date":"2022-04-14","current":25.865073,"twenty":12.119208,"median":13.175276,"eighty":14.953028,"marketCap":13248598872},{"date":"2022-04-22","current":24.501555,"twenty":12.191086,"median":13.216054,"eighty":20.896029,"marketCap":12315598951},{"date":"2022-04-29","current":23.770426,"twenty":12.311154,"median":13.345619,"eighty":23.810765,"marketCap":11755798999},{"date":"2022-05-06","current":19.97461,"twenty":12.403513,"median":13.387495,"eighty":23.824211,"marketCap":9796499166},{"date":"2022-05-13","current":22.275517,"twenty":12.497547,"median":13.437855,"eighty":23.770426,"marketCap":10729499086},{"date":"2022-05-20","current":23.495458,"twenty":12.566572,"median":13.505367,"eighty":23.495458,"marketCap":11475899023},{"date":"2022-05-27","current":20.456885,"twenty":12.635159,"median":13.600429,"eighty":23.495458,"marketCap":9983099150},{"date":"2022-06-02","current":22.059164,"twenty":12.719893,"median":13.891083,"eighty":23.428031,"marketCap":10822799078},{"date":"2022-06-10","current":22.782826,"twenty":12.818914,"median":14.187223,"eighty":23.405861,"marketCap":11102699055},{"date":"2022-06-17","current":22.61617,"twenty":12.869426,"median":14.893251,"eighty":23.399001,"marketCap":11009399063},{"date":"2022-06-24","current":24.053703,"twenty":12.896899,"median":15.198068,"eighty":23.405861,"marketCap":11755798999},{"date":"2022-06-30","current":24.477649,"twenty":12.909045,"median":17.731175,"eighty":23.688539,"marketCap":11942398983},{"date":"2022-07-08","current":24.643513,"twenty":12.91967,"median":20.576157,"eighty":24.071679,"marketCap":12035698975},{"date":"2022-07-15","current":21.788884,"twenty":12.926947,"median":21.331232,"eighty":24.071679,"marketCap":10542899102},{"date":"2022-07-22","current":22.738077,"twenty":12.951049,"median":21.927975,"eighty":23.924075,"marketCap":11009399063},{"date":"2022-07-29","current":21.55561,"twenty":12.971081,"median":21.986908,"eighty":23.797318,"marketCap":10449599110},{"date":"2022-08-05","current":21.417702,"twenty":12.984459,"median":21.788884,"eighty":23.729375,"marketCap":10356299118},{"date":"2022-08-12","current":21.388554,"twenty":12.99735,"median":21.539113,"eighty":23.688539,"marketCap":10356299118},{"date":"2022-08-19","current":19.074515,"twenty":13.008905,"median":21.417702,"eighty":23.569099,"marketCap":9143399221},{"date":"2022-08-26","current":20.011662,"twenty":13.057307,"median":21.382076,"eighty":23.444888,"marketCap":9516599190},{"date":"2022-09-02","current":-50.414444,"twenty":12.984459,"median":21.247144,"eighty":23.407189,"marketCap":8863499245},{"date":"2022-09-09","current":-50.607103,"twenty":12.91967,"median":20.858756,"eighty":23.400384,"marketCap":8863499245},{"date":"2022-09-16","current":-47.853042,"twenty":12.853899,"median":20.604805,"eighty":23.393338,"marketCap":8303699293},{"date":"2022-09-23","current":-43.307663,"twenty":12.525157,"median":20.456885,"eighty":23.36815,"marketCap":7370699372},{"date":"2022-09-30","current":-41.583628,"twenty":12.107991,"median":19.993136,"eighty":23.33352,"marketCap":7090799396},{"date":"2022-10-07","current":-42.133205,"twenty":12.06485,"median":19.637124,"eighty":23.316565,"marketCap":7184099388},{"date":"2022-10-14","current":-40.925738,"twenty":11.919829,"median":19.38703,"eighty":23.276922,"marketCap":6904199412},{"date":"2022-10-21","current":-41.207935,"twenty":11.75473,"median":18.999282,"eighty":23.214673,"marketCap":6904199412},{"date":"2022-10-28","current":-37.373897,"twenty":-27.390428,"median":15.48774,"eighty":23.127451,"marketCap":6251099468},{"date":"2022-11-04","current":-43.090604,"twenty":-38.423466,"median":14.959982,"eighty":23.068326,"marketCap":7277399380},{"date":"2022-11-11","current":-44.352681,"twenty":-39.706495,"median":14.612812,"eighty":22.970466,"marketCap":7557299356},{"date":"2022-11-18","current":-49.450162,"twenty":-40.88532,"median":13.933713,"eighty":22.927159,"marketCap":8396999285},{"date":"2022-11-25","current":-45.968734,"twenty":-42.005475,"median":13.75323,"eighty":22.88204,"marketCap":7743899340},{"date":"2022-12-02","current":-46.277717,"twenty":-42.783845,"median":13.548021,"eighty":22.8258,"marketCap":7930499325},{"date":"2022-12-09","current":-49.088418,"twenty":-43.299013,"median":13.457621,"eighty":22.784854,"marketCap":8490299277},{"date":"2022-12-16","current":-50.825271,"twenty":-44.19667,"median":13.388939,"eighty":22.776063,"marketCap":8770199253},{"date":"2022-12-23","current":-48.647344,"twenty":-44.632402,"median":13.345619,"eighty":22.746825,"marketCap":8396999285},{"date":"2022-12-30","current":-50.733601,"twenty":-44.88627,"median":13.246799,"eighty":22.740264,"marketCap":8863499245},{"date":"2023-01-06","current":-53.389335,"twenty":-45.265509,"median":13.18968,"eighty":22.735439,"marketCap":9423299198},{"date":"2023-01-13","current":-53.424808,"twenty":-45.938929,"median":13.15501,"eighty":22.731574,"marketCap":9609899182},{"date":"2023-01-20","current":-52.840862,"twenty":-46.59674,"median":13.05005,"eighty":22.727682,"marketCap":9423299198},{"date":"2023-01-27","current":-54.922334,"twenty":-47.03062,"median":13.007691,"eighty":22.726024,"marketCap":9796499166},{"date":"2023-02-03","current":-57.761641,"twenty":-47.472906,"median":12.974732,"eighty":22.707873,"marketCap":10356299118},{"date":"2023-02-10","current":-52.875612,"twenty":-47.832379,"median":12.92638,"eighty":22.61617,"marketCap":9423299198},{"date":"2023-02-17","current":-50.737918,"twenty":-48.647344,"median":12.901826,"eighty":22.608311,"marketCap":8956799237},{"date":"2023-02-24","current":-49.760718,"twenty":-49.165946,"median":12.789725,"eighty":22.583157,"marketCap":8676899261},{"date":"2023-03-03","current":-51.036808,"twenty":-49.265743,"median":12.566572,"eighty":22.527072,"marketCap":8956799237},{"date":"2023-03-10","current":-43.382514,"twenty":-48.330408,"median":-46.012402,"eighty":-43.703866,"marketCap":7557299356},{"date":"2023-03-17","current":-43.497246,"twenty":-11.799375,"median":9.135444,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-24","current":-43.003515,"twenty":-11.923183,"median":9.108489,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-31","current":-3.369265,"twenty":-11.914105,"median":9.06444,"eighty":13.922755,"marketCap":7370699372},{"date":"2023-04-06","current":-3.499469,"twenty":-11.905028,"median":9.059545,"eighty":13.910863,"marketCap":7650599348},{"date":"2023-04-14","current":-3.62392,"twenty":-11.923183,"median":8.997567,"eighty":13.934648,"marketCap":7930499325},{"date":"2023-04-21","current":-3.412504,"twenty":-11.923183,"median":8.985211,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-04-28","current":-3.438104,"twenty":-11.923183,"median":8.941609,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-05-05","current":-3.475381,"twenty":-11.923183,"median":8.913332,"eighty":13.934648,"marketCap":7557299356},{"date":"2023-05-12","current":-3.369868,"twenty":-11.923183,"median":8.886738,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-05-19","current":-3.374111,"twenty":-11.923183,"median":8.84028,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-05-25","current":-3.344052,"twenty":-11.914105,"median":8.76622,"eighty":13.922755,"marketCap":7090799396},{"date":"2023-06-02","current":-3.399581,"twenty":-11.923183,"median":8.634294,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-06-09","current":-3.271849,"twenty":-11.923183,"median":8.544591,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-16","current":-3.287594,"twenty":-11.923183,"median":8.325238,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-23","current":-3.260953,"twenty":-11.923183,"median":8.22569,"eighty":13.934648,"marketCap":6810899420},{"date":"2023-06-30","current":-3.516112,"twenty":-11.923183,"median":8.122554,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-07-07","current":-3.387485,"twenty":-11.914105,"median":8.052356,"eighty":13.922755,"marketCap":6997499404},{"date":"2023-07-14","current":-3.296067,"twenty":-11.914105,"median":7.77723,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-21","current":-3.311457,"twenty":-11.914105,"median":7.356217,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-28","current":-3.449398,"twenty":-11.914105,"median":-2.287019,"eighty":13.922755,"marketCap":7184099388},{"date":"2023-08-04","current":-3.264781,"twenty":-11.914105,"median":-2.31585,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-11","current":-3.28332,"twenty":-11.914105,"median":-2.324398,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-18","current":-2.899285,"twenty":-11.914105,"median":-2.339675,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-08-25","current":-2.988413,"twenty":-11.914105,"median":-2.355562,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-01","current":-2.756299,"twenty":-11.914105,"median":-2.368431,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-08","current":-2.832715,"twenty":-11.914105,"median":-2.388209,"eighty":13.922755,"marketCap":6064499483},{"date":"2023-09-15","current":-2.854165,"twenty":-11.914105,"median":-2.395927,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-22","current":-2.779829,"twenty":-11.914105,"median":-2.415497,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-29","current":-2.644988,"twenty":-11.905028,"median":-2.420333,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-10-06","current":-2.602874,"twenty":-11.905028,"median":-2.422655,"eighty":13.910863,"marketCap":5597999523},{"date":"2023-10-13","current":-2.737106,"twenty":-11.905028,"median":-2.427741,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-10-20","current":-2.654304,"twenty":-11.89595,"median":-2.443134,"eighty":13.898971,"marketCap":5691299515},{"date":"2023-10-27","current":-2.655443,"twenty":-11.905028,"median":-2.448372,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-11-03","current":-2.908911,"twenty":-11.905028,"median":-2.473666,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-10","current":-2.866093,"twenty":-11.905028,"median":-2.484636,"eighty":13.910863,"marketCap":6157799475},{"date":"2023-11-17","current":-2.883513,"twenty":-11.905028,"median":-2.491565,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-24","current":-2.988026,"twenty":-11.905028,"median":-2.505676,"eighty":13.910863,"marketCap":6530999444},{"date":"2023-12-01","current":-2.848158,"twenty":-11.905028,"median":-2.536149,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-12-08","current":-2.646304,"twenty":-11.905028,"median":-2.561957,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-15","current":-2.673547,"twenty":-11.905028,"median":-2.583157,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-12-22","current":-2.632869,"twenty":-11.905028,"median":-2.607761,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-29","current":-2.745627,"twenty":-11.905028,"median":-2.60984,"eighty":13.910863,"marketCap":6064499483},{"date":"2024-01-05","current":-2.637506,"twenty":-11.905028,"median":-2.639856,"eighty":13.910863,"marketCap":5784599507},{"date":"2024-01-12","current":-2.678621,"twenty":-11.905028,"median":-2.644988,"eighty":13.910863,"marketCap":5877899499},{"date":"2024-01-19","current":-2.426848,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5318099547},{"date":"2024-01-26","current":-2.479072,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5411399539},{"date":"2024-02-02","current":-2.182657,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":4758299595},{"date":"2024-02-09","current":-2.342311,"twenty":-11.895406,"median":-2.644096,"eighty":13.898608,"marketCap":5131499563},{"date":"2024-02-16","current":-2.384382,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5224799555},{"date":"2024-02-23","current":-2.482626,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5411399539},{"date":"2024-03-01","current":-2.438302,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-08","current":-2.351702,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5131499563},{"date":"2024-03-15","current":-2.482173,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5411399539},{"date":"2024-03-22","current":-2.441611,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-28","current":-2.277553,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":4944899579},{"date":"2024-04-05","current":-82.564306,"twenty":-12.024696,"median":-2.653901,"eighty":13.922755,"marketCap":4826414427},{"date":"2024-04-12","current":-82.517453,"twenty":-12.053439,"median":-2.678022,"eighty":13.910863,"marketCap":4826414427},{"date":"2024-04-19","current":-80.999729,"twenty":-12.172703,"median":-2.681735,"eighty":13.910863,"marketCap":4733598765},{"date":"2024-04-26","current":-89.050676,"twenty":-12.294617,"median":-2.696365,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-05-03","current":-97.068727,"twenty":-12.347799,"median":-2.720997,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-10","current":-100.013862,"twenty":-12.43199,"median":-2.742169,"eighty":13.89879,"marketCap":5847386709},{"date":"2024-05-17","current":-96.981169,"twenty":-12.561565,"median":-2.775562,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-24","current":-90.829186,"twenty":-12.802369,"median":-2.783534,"eighty":13.89879,"marketCap":5290492737},{"date":"2024-05-31","current":-85.961213,"twenty":-12.9722,"median":-2.82109,"eighty":13.89879,"marketCap":5012045751},{"date":"2024-06-07","current":-82.880248,"twenty":-13.0747,"median":-2.850331,"eighty":13.89879,"marketCap":4826414427},{"date":"2024-06-14","current":-89.337509,"twenty":-13.162465,"median":-2.855147,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-06-21","current":-87.926264,"twenty":-13.350566,"median":-2.866093,"eighty":13.89879,"marketCap":5104861413},{"date":"2024-06-28","current":-83.075186,"twenty":-13.539773,"median":-2.899285,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-07-05","current":-87.887073,"twenty":-13.831871,"median":-2.914912,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-12","current":-89.353766,"twenty":-23.129881,"median":-2.937581,"eighty":13.89879,"marketCap":5192077075},{"date":"2024-07-19","current":-87.75652,"twenty":-27.49497,"median":-2.962287,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-26","current":-82.662699,"twenty":-29.481842,"median":-2.988026,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-02","current":-82.710896,"twenty":-31.051397,"median":-2.992606,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-09","current":-83.743358,"twenty":-31.528775,"median":-3.16992,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-16","current":-85.290276,"twenty":-32.152303,"median":-3.229351,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-08-23","current":-83.358505,"twenty":-32.890641,"median":-3.231225,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-30","current":-84.364924,"twenty":-35.838782,"median":-3.231225,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-09-06","current":-122.742481,"twenty":-37.338415,"median":-3.231225,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-09-13","current":-116.352005,"twenty":-39.121822,"median":-3.231225,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-09-20","current":-120.106819,"twenty":-40.50159,"median":-3.230288,"eighty":13.898971,"marketCap":5006645751},{"date":"2024-09-27","current":-128.90228,"twenty":-41.473142,"median":-3.230288,"eighty":13.898971,"marketCap":5405599539},{"date":"2024-10-04","current":-160.746776,"twenty":-42.353423,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-10-10","current":-166.288706,"twenty":-42.783845,"median":-3.231225,"eighty":13.89879,"marketCap":6896799412},{"date":"2024-10-18","current":-160.383543,"twenty":-43.090604,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-10-25","current":-160.393712,"twenty":-43.385987,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-11-01","current":-162.543207,"twenty":-43.918101,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-11-08","current":-165.551727,"twenty":-44.601068,"median":-3.230288,"eighty":13.898971,"marketCap":6803599420},{"date":"2024-11-15","current":-153.57094,"twenty":-45.087779,"median":-3.230288,"eighty":13.898971,"marketCap":6244399468},{"date":"2024-11-22","current":-151.350528,"twenty":-45.919059,"median":-3.230288,"eighty":13.898971,"marketCap":6151199475},{"date":"2024-11-29","current":-158.1664,"twenty":-46.947732,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-06","current":-158.539828,"twenty":-47.472906,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-13","current":-156.551131,"twenty":-47.853042,"median":-3.230288,"eighty":13.898971,"marketCap":6330799460},{"date":"2024-12-20","current":-152.622975,"twenty":-48.647344,"median":-3.230288,"eighty":13.898971,"marketCap":6144599475},{"date":"2024-12-27","current":-150.427207,"twenty":-48.748259,"median":-3.230288,"eighty":13.898971,"marketCap":6051499483},{"date":"2025-01-03","current":-145.65607,"twenty":-49.231765,"median":-3.230288,"eighty":13.898971,"marketCap":5865299499},{"date":"2025-01-10","current":-134.606092,"twenty":-49.760718,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-17","current":-134.497552,"twenty":-50.352943,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-24","current":-131.355559,"twenty":-50.737918,"median":-3.230288,"eighty":13.898971,"marketCap":5306699547},{"date":"2025-01-28","current":-135.255702,"twenty":-50.821082,"median":-3.231225,"eighty":13.89879,"marketCap":5492899531},{"date":"2025-02-07","current":-133.7198,"twenty":-51.348886,"median":-3.229351,"eighty":13.910863,"marketCap":5399799539},{"date":"2025-02-14","current":-143.010767,"twenty":-51.820483,"median":-3.229351,"eighty":13.910863,"marketCap":5772199507},{"date":"2025-02-21","current":-140.204067,"twenty":-52.541209,"median":-3.229351,"eighty":13.910863,"marketCap":5679099515},{"date":"2025-02-28","current":-136.055611,"twenty":-52.889352,"median":-3.229351,"eighty":13.910863,"marketCap":5492899531},{"date":"2025-03-07","current":-140.105142,"twenty":-53.292951,"median":-3.228493,"eighty":13.922755,"marketCap":5679099515},{"date":"2025-03-14","current":-137.758216,"twenty":-53.706159,"median":-3.228493,"eighty":13.922755,"marketCap":5585999523},{"date":"2025-03-21","current":-146.841923,"twenty":-54.405044,"median":-3.228493,"eighty":13.922755,"marketCap":5951999491},{"date":"2025-03-28","current":-137.943443,"twenty":-56.391895,"median":-3.241626,"eighty":13.922755,"marketCap":5579999523},{"date":"2025-04-03","current":-26.523264,"twenty":-56.391895,"median":-3.251132,"eighty":13.922755,"marketCap":6137999475},{"date":"2025-04-11","current":-25.486974,"twenty":-56.391895,"median":-3.265745,"eighty":13.922755,"marketCap":5858999499},{"date":"2025-04-17","current":-25.150028,"twenty":-56.370327,"median":-3.279167,"eighty":13.910863,"marketCap":5795411709},{"date":"2025-04-25","current":-26.324914,"twenty":-56.413464,"median":-3.301031,"eighty":13.934648,"marketCap":6071383695},{"date":"2025-05-02","current":-29.45321,"twenty":-56.391895,"median":-3.309311,"eighty":13.922755,"marketCap":6807308992},{"date":"2025-05-09","current":-27.542361,"twenty":-56.413464,"median":-3.312987,"eighty":13.934648,"marketCap":6410355844},{"date":"2025-05-16","current":-26.119791,"twenty":-56.413464,"median":-3.359803,"eighty":13.934648,"marketCap":6128926308},{"date":"2025-05-23","current":-34.592965,"twenty":-56.413464,"median":-3.369868,"eighty":13.934648,"marketCap":8141409573},{"date":"2025-05-30","current":-37.924397,"twenty":-56.413464,"median":-3.387485,"eighty":13.934648,"marketCap":8964698181},{"date":"2025-06-06","current":-39.757882,"twenty":-56.413464,"median":-3.411914,"eighty":13.934648,"marketCap":9422080742},{"date":"2025-06-13","current":-44.75817,"twenty":-56.413464,"median":-3.415949,"eighty":13.934648,"marketCap":10611275398},{"date":"2025-06-20","current":-41.276192,"twenty":-56.413464,"median":-3.420731,"eighty":13.934648,"marketCap":9766586790},{"date":"2025-06-27","current":-42.699652,"twenty":-56.391895,"median":-3.438104,"eighty":13.922755,"marketCap":10131692838},{"date":"2025-07-04","current":-41.543655,"twenty":-56.391895,"median":-3.44468,"eighty":13.922755,"marketCap":9857863302},{"date":"2025-07-11","current":-46.206161,"twenty":-56.391895,"median":-3.469159,"eighty":13.922755,"marketCap":10953181447},{"date":"2025-07-18","current":-53.564112,"twenty":-56.391895,"median":-3.482303,"eighty":13.922755,"marketCap":12687435176},{"date":"2025-07-25","current":-51.066284,"twenty":-56.391895,"median":-3.514529,"eighty":13.922755,"marketCap":12139776103},{"date":"2025-08-01","current":-50.22475,"twenty":-56.391895,"median":-3.589151,"eighty":13.922755,"marketCap":11865946567},{"date":"2025-08-08","current":-53.18247,"twenty":-56.391895,"median":-7.200248,"eighty":13.922755,"marketCap":12596158664},{"date":"2025-08-15","current":-55.192072,"twenty":-56.391895,"median":-11.122318,"eighty":13.922755,"marketCap":13052541224},{"date":"2025-08-22","current":-55.752863,"twenty":-57.774713,"median":-11.335383,"eighty":13.922755,"marketCap":13143817736},{"date":"2025-08-29","current":-56.258629,"twenty":-57.774713,"median":-11.34716,"eighty":13.922755,"marketCap":13326370760},{"date":"2025-09-05","current":-171.005462,"twenty":-80.999729,"median":-11.34716,"eighty":13.922755,"marketCap":15060624489},{"date":"2025-09-12","current":-173.767346,"twenty":-82.276481,"median":-11.34716,"eighty":13.922755,"marketCap":15331415304},{"date":"2025-09-19","current":-169.725699,"twenty":-82.58333,"median":-11.34716,"eighty":13.922755,"marketCap":14964195775},{"date":"2025-09-26","current":-153.463683,"twenty":-82.851859,"median":-11.34716,"eighty":13.922755,"marketCap":13495317662},{"date":"2025-10-03","current":-185.056471,"twenty":-83.064154,"median":-11.352265,"eighty":13.910863,"marketCap":16312368818},{"date":"2025-10-10","current":-169.796368,"twenty":-83.220688,"median":-11.348775,"eighty":13.922755,"marketCap":14945410537},{"date":"2025-10-17","current":-151.277947,"twenty":-83.756141,"median":-11.37254,"eighty":13.922755,"marketCap":13305060600},{"date":"2025-10-24","current":-146.676373,"twenty":-84.447774,"median":-11.37254,"eighty":13.922755,"marketCap":12905038392},{"date":"2025-10-31","current":-152.64629,"twenty":-84.624193,"median":-11.37254,"eighty":13.922755,"marketCap":13450321704},{"date":"2025-11-07","current":-144.485392,"twenty":-85.250381,"median":-11.37254,"eighty":13.922755,"marketCap":12723277288},{"date":"2025-11-14","current":-147.164496,"twenty":-85.777895,"median":-11.37254,"eighty":13.922755,"marketCap":12995918944},{"date":"2025-11-21","current":-133.84826,"twenty":-86.066041,"median":-11.37254,"eighty":13.922755,"marketCap":11814471767},{"date":"2025-11-28","current":-138.493216,"twenty":-86.277112,"median":-11.37254,"eighty":13.922755,"marketCap":12268874528},{"date":"2025-12-05","current":-136.207289,"twenty":-87.682255,"median":-11.37254,"eighty":13.922755,"marketCap":12087113423},{"date":"2025-12-12","current":-133.911368,"twenty":-87.902749,"median":-11.37254,"eighty":13.922755,"marketCap":11905352319},{"date":"2025-12-19","current":-128.497409,"twenty":-89.023351,"median":-11.37254,"eighty":13.922755,"marketCap":11450949559},{"date":"2025-12-24","current":-129.115057,"twenty":-89.343343,"median":-11.58276,"eighty":13.922755,"marketCap":11541830111},{"date":"2026-01-02","current":-129.621563,"twenty":-89.385148,"median":-11.776052,"eighty":13.934648,"marketCap":11632710663},{"date":"2026-01-09","current":-133.340226,"twenty":-90.855167,"median":-22.789601,"eighty":13.934648,"marketCap":11996232871},{"date":"2026-01-16","current":-135.809309,"twenty":-96.214774,"median":-24.4212,"eighty":13.934648,"marketCap":12258074528},{"date":"2026-01-23","current":-134.932765,"twenty":-97.941067,"median":-25.252446,"eighty":13.934648,"marketCap":12167273976},{"date":"2026-01-30","current":-158.375813,"twenty":-100.15633,"median":-25.653279,"eighty":13.934648,"marketCap":14346487225},{"date":"2026-02-06","current":-163.974176,"twenty":-116.245243,"median":-25.653279,"eighty":13.934648,"marketCap":14891290537},{"date":"2026-02-13","current":-162.043578,"twenty":-120.222251,"median":-25.684915,"eighty":13.922755,"marketCap":14800489985},{"date":"2026-02-20","current":-168.250715,"twenty":-121.922853,"median":-25.570127,"eighty":13.94654,"marketCap":15345293298},{"date":"2026-02-27","current":-152.638791,"twenty":-123.147379,"median":-25.570127,"eighty":13.94654,"marketCap":14074085569},{"date":"2026-03-06","current":-145.937152,"twenty":-125.836872,"median":-25.570127,"eighty":13.94654,"marketCap":13347681152},{"date":"2026-03-13","current":-141.315211,"twenty":-128.463999,"median":-25.570127,"eighty":13.94654,"marketCap":12984478944},{"date":"2026-03-20","current":-136.89247,"twenty":-128.88509,"median":-25.570127,"eighty":13.94654,"marketCap":12530476184},{"date":"2026-03-27","current":-135.252627,"twenty":-129.286477,"median":-26.222352,"eighty":13.872469,"marketCap":12348875080},{"date":"2026-04-02","current":62.622294,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12802877840},{"date":"2026-04-10","current":62.758937,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12929774294},{"date":"2026-04-17","current":58.345701,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12025594273},{"date":"2026-04-24","current":57.903729,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11935176271},{"date":"2026-04-30","current":55.696119,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11483086261},{"date":"2026-05-08","current":53.318298,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":11030996251},{"date":"2026-05-15","current":47.947764,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":9945980226},{"date":"2026-05-22","current":45.436272,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":9403472214},{"date":"2026-05-29","current":41.795837,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8680128197},{"date":"2026-06-05","current":40.865781,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-12","current":40.893441,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-18","current":37.757596,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":7866366179},{"date":"2026-06-26","current":36.11832,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7488094170},{"date":"2026-07-03","current":38.700332,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8029402183},{"date":"2026-07-10","current":37.006407,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7668530175},{"date":"2026-07-17","current":37.309002,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7758748177},{"date":"2026-07-24","current":38.168077,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7939184181},{"date":"2026-07-31","current":38.961518,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8119620185},{"date":"2026-08-07","current":39.102047,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8164729186},{"date":"2026-08-14","current":37.110765,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7758748177},{"date":"2026-08-21","current":37.674785,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7894075180},{"date":"2026-08-28","current":19.934666,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7016724160},{"date":"2026-09-04","current":20.054401,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7061703161},{"date":"2026-09-11","current":18.369057,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":6476976148},{"date":"2026-09-18","current":18.345087,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":6476976148},{"date":"2026-09-25","current":18.380118,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":6476976148},{"date":"2026-10-02","current":18.36076,"twenty":-129.621563,"median":-26.410489,"eighty":13.874132,"marketCap":6476976148},{"date":"2026-10-07","current":18.207255,"twenty":-129.621563,"median":-26.410489,"eighty":13.898064,"marketCap":6431997147}],"updateTime":1791460856356},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00460\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192782541","title":"Sihuan Pharmaceutical Proposes 2026 Share Incentive Scheme to Replace Existing Option Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1192782541","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192782541?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:43","pubTimestamp":1778229811,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical has unveiled plans to adopt a 2026 Share Incentive Scheme, aiming to strengthen its long-term talent incentives and align employee interests with the Group’s strategic goals in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150772296","title":"SIHUAN PHARM (00460) Proposes Adoption of 2026 Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1150772296","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150772296?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:40","pubTimestamp":1778229619,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that on May 8, 2026, the board of directors proposed the adoption of a 2026 share incentive plan. The 2026 share incentive plan will constitute a share scheme under...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633435973","title":"Sihuan Pharmaceutical proposes adopting 2026 share incentive scheme to replace option plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633435973?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:36","pubTimestamp":1778229368,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group resolved May 8, 2026 to propose adoption of a 2026 Share Incentive Scheme under Chapter 17 share scheme framework.Plan would replace 2017 Share Option Scheme; no further options would be granted under 2017 scheme once 2026 scheme takes effect.Existing, unexercised options granted under 2017 scheme would remain valid and exercisable under their original terms.Implementation is conditional on shareholder approval at a general meeting, plus Stock Exchange approval for listing and dealing in shares issued for awards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Serv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL5r7Zgt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633972524","title":"There May Be Underlying Issues With The Quality Of Sihuan Pharmaceutical Holdings Group's (HKG:460) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2633972524","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633972524?lang=en_us&edition=fundamental","pubTime":"2026-05-06 07:18","pubTimestamp":1778023095,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd.'s ( HKG:460 ) robust earnings report didn't manage to move the market for its...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/there-may-be-underlying-issues-with-the-quality-of-sihuan-ph","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/there-may-be-underlying-issues-with-the-quality-of-sihuan-ph","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157564044","title":"Sihuan Pharmaceutical Reports No Share Capital Changes for April; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1157564044","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157564044?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:24","pubTimestamp":1777883044,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical) filed its Monthly Return for April 2026, confirming that both authorised and issued share capital were unchanged during the period....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141785251","title":"四环医药控股集团2025年业绩回顾：营收同比增长37.7%，成功实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1141785251","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141785251?lang=en_us&edition=fundamental","pubTime":"2026-04-27 16:49","pubTimestamp":1777279740,"startTime":"0","endTime":"0","summary":"四环医药控股集团（“四环医药”）于2025年度在医美与生物医药“双轮”战略下取得显著营运进展，主营业务涵盖创新药、医疗美容、代谢糖尿病、肿瘤、心脑血管疾病等治疗领域。公司自2001年成立以来，不断完善自主生产及研发平台，已于2010年在香港联合交易所有限公司主板上市。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"四环医药控股集团2025年业绩回顾：营收同比增长37.7%，成功实现扭亏为盈","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101324502","title":"SIHUAN PHARM Publishes FY2025 Annual Report and ESG Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1101324502","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101324502?lang=en_us&edition=fundamental","pubTime":"2026-04-27 16:45","pubTimestamp":1777279506,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM disclosed that both the English and Chinese versions of its FY2025 Annual Report and the ESG Report 2025 are now available on the company website (www.sihuanpharm.com) and on HKExnews...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128977192","title":"SIHUAN PHARM (00460) Trustee Acquires 3 Million Shares Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1128977192","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128977192?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:36","pubTimestamp":1776767771,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that on April 21, 2026, the trustee purchased a total of 3 million company shares on the market under the share incentive scheme.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629080526","title":"Sihuan Pharmaceutical share award scheme trustee buys 3,000,000 shares at HK$1.36 average","url":"https://stock-news.laohu8.com/highlight/detail?id=2629080526","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629080526?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:30","pubTimestamp":1776767406,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical trustee bought 3,000,000 shares on-market on April 21, 2026 under 2022 share award scheme.Average purchase price was HKD 1.36 per share.Purchased shares represented about 0.03% of issued shares, excluding treasury shares, as of announcement date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL8RdXBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141536607","title":"SIHUAN PHARM Shares Climb Nearly 3% as Subsidiary XUANZHUBIO-B Presents Promising Data on Diraoc in First-Line NSCLC Treatment at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=1141536607","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141536607?lang=en_us&edition=fundamental","pubTime":"2026-04-21 11:40","pubTimestamp":1776742822,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) rose nearly 3%, with the stock up 2.29% to HK$1.34 at the time of writing. Turnover reached HK$18.04 million. The increase follows an announcement on April 20 that the group's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1191","VXUS","BK4588","00460","02575","BK1593","BK1600","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628574340","title":"Xuanzhu says Phase 1b NG-350A plus chemoradiotherapy hits 50% composite response rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2628574340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628574340?lang=en_us&edition=fundamental","pubTime":"2026-04-20 16:51","pubTimestamp":1776675091,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical announced preliminary Phase 1b FORTRESS data for NG-350A were presented at 2026 AACR on April 20, 2026.Early results indicated NG-350A combined with chemoradiotherapy improved response outcomes in mismatch repair-proficient locally advanced rectal cancer versus expectations for chemoradiotherapy alone.Safety profile appeared supportive, with no serious adverse events or new safety signals attributed to NG-350A in initial patients completing active treatment.Program supports Xuanzhu strategy to advance NG-350A development in Greater China under an exclusive license from Akamis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL95R4QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02575","BK1191","00460","BK1600","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628371526","title":"Sihuan Pharma - Dirozalkib Shows Significant Efficacy Advantages in First-Line Alk-Positive Advanced Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2628371526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628371526?lang=en_us&edition=fundamental","pubTime":"2026-04-20 12:00","pubTimestamp":1776657637,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN41100R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00460","BK1593","BK1600","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628237715","title":"Sihuan Pharma - Xuanzhu Biopharm Presents Phase Iii Dirozalkib Data for Alk-Positive Nsclc at 2026 Aacr","url":"https://stock-news.laohu8.com/highlight/detail?id=2628237715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628237715?lang=en_us&edition=fundamental","pubTime":"2026-04-20 12:00","pubTimestamp":1776657637,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN41100R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1600","BK1593","BK1515","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628076134","title":"Xuanzhu says Phase III trial shows dirozalkib cuts lung cancer progression risk 53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628076134","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628076134?lang=en_us&edition=fundamental","pubTime":"2026-04-19 18:07","pubTimestamp":1776593223,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical presented Phase III DIAMOND-2 trial results for ALK-positive advanced non-small cell lung cancer at 2026 AACR, held April 17-22, 2026.Dirozalkib outperformed crizotinib in first-line treatment, extending time without disease worsening in a 275-patient China study.Study also showed stronger tumor shrinkage durability, including improved control of brain lesions versus comparator.Safety profile supported continued use, with mostly mild-to-moderate gastrointestinal side effects.Dirozalkib received China NMPA clearance in August 2025 for ALK-positive locally advanced or metastatic NSCLC in patients not previously treated with an ALK inhibitor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260419:nNDL4PxWxZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02575","BK1515","BK1600","00460","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628134279","title":"Xuanzhu Biopharma wins HKEX approval to list 357,245,794 converted H shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2628134279","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628134279?lang=en_us&edition=fundamental","pubTime":"2026-04-17 16:31","pubTimestamp":1776414695,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange cleared Xuanzhu Biopharmaceutical to list 357,245,794 H shares converted from unlisted shares under its H-share full circulation plan.Transaction would lift total listed H shares to 517,947,790 from 160,701,996 once conversion and trading procedures are completed.Xuanzhu flagged additional updates as it moves toward completion of conversion and listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL24Xh0W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1515","BK1600","02575","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165366587","title":"Sihuan Pharm’s Xuanzhu Biopharm Secures CDE Approval for Phase III Trial of Anaprazole Sodium in Helicobacter Pylori Eradication","url":"https://stock-news.laohu8.com/highlight/detail?id=1165366587","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165366587?lang=en_us&edition=fundamental","pubTime":"2026-04-15 12:21","pubTimestamp":1776226883,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharm) announced that its non-wholly-owned subsidiary, Xuanzhu Biopharmaceutical Co., Ltd., has received clearance from China’s Center for Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627502471","title":"BUZZ-Xuanzhu Biopharmaceutical climbs to three-week high on approval for drug clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627502471","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627502471?lang=en_us&edition=fundamental","pubTime":"2026-04-15 10:21","pubTimestamp":1776219698,"startTime":"0","endTime":"0","summary":"BUZZ-Xuanzhu Biopharmaceutical climbs to three-week high on approval for drug clinical trial    ** Shares of Xuanzhu Biopharmaceutical 2575.HK jump as much as 25.8% to HK$41, their highest level since March 26** Stock marks its biggest one-day pct rise since October 22** Xuanzhu says China's National Medical Products Administration has approved the company to initiate a Phase III clinical trial of bismuth-containing quadruple therapy comprising Anaprazole Sodium Enteric-coated tablets for the eradication of Helicobacter pylori** The market size of drugs for treatment of Helicobacter pylori, which closely associated with gastric diseases including gastric ulcer, chronic progressive gastritis and gastric cancer, reached 5.5 billion yuan  in 2024, and is projected to reach 6.8 billion yuan in 2029 and to 12.6 billion yuan in 2035, says Xuanzhu ** The approval of the Phase III clinical trial application for the new indication of Anaprazole Sodium helps to enhance the company's influence in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL1N40Y01E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","00460","02575","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627542752","title":"Xuanzhu Biopharma wins China CDE nod for Phase III Anaprazole H. pylori trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627542752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627542752?lang=en_us&edition=fundamental","pubTime":"2026-04-15 06:07","pubTimestamp":1776204421,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical secured China CDE clearance to start Phase III trial of bismuth-containing quadruple therapy using Anaprazole Sodium for Helicobacter pylori eradication.Study targets enrollment of 556 adults, with primary endpoint H. pylori eradication rate confirmed by 13C-urea breath test on day 28.Anaprazole Sodium was approved in China in June 2023 for duodenal ulcer, with new Phase III program aimed at expanding its label into digestive diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 14, 2026, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL9fwX0k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","02575","BK1593","BK1600","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":98,"code":"91000000","status":"200"}]}}